Skip to main content
Signal8

Derynck Mika K

SEC insider (Form 3/4/5 filer). CIK 0001865125. Director at Enliven Therapeutics, Inc. (ELVN). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 4, 2026. Located in BURLINGAME, CA.

Companies Derynck Mika K has filed insider reports for

  • Enliven Therapeutics, Inc. (ELVN): Director
Derynck Mika K profile photo

Derynck Mika K

CIK: 0001865125

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)4 (57.1%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Enliven Therapeutics, Inc. logo
ELVN

Enliven Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 4, 2026
    Exercise
    Direct
    20.5K shares at avg. $22.47$460K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 4, 2026
    Exercise
    Direct
    27.6K shares at avg. $25.28$697K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 4, 2026
    Exercise
    Direct
    23.4K shares at avg. $14.85$347K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 4, 2026
    Exercise
    Direct
    87.4K shares at avg. $2.48$217K
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Aug 4, 2026
    Sale
    Direct
    158.8K shares at avg. $60.21$9.6M
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Feb 12, 2026
    Award

    Stock Option (right to buy)

    Direct
    17.1K shares-
  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Feb 6, 2025
    Award

    Stock Option (right to buy)

    Direct
    20.5K shares-

1-7 of 7